Iowa Diabetes and Endocrinology Research Center | West Des Moines, IA
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safety with LY3841136 compared with placebo in adult participants with obesity or overweight. The study will last about 64 weeks and may include up to 13 visits.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
W8M-MC-LAA1
W8M-MC-CWMM:
BMI ≥30 kilograms per square meter (kg/m²) or
Have a BMI ≥27 kg/m² and <30 kg/m² with at least one of the following weight-related comorbidities:
Have had a stable body weight for the 3 months prior to randomization (<5% body weight gain and/or loss)
Exclusion criteria
W8M-MC-LAA1
Have any prior diagnosis of diabetes mellitus except gestational diabetes.
Have any of the following cardiovascular conditions within 6 months prior to screening:
Have a history of acute or chronic pancreatitis.
Have an on-going or history of bradyarrhythmia and/or sinus bradycardia at screening and baseline.
W8M-MC-CWMM
Primary purpose
Allocation
Interventional model
Masking
250 participants in 7 patient groups, including a placebo group
Loading...
Central trial contact
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal